about
The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2Expression of Toll-like receptors in murine vaginal epithelium is affected by the estrous cycle and stromal cells.Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocationEffects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tractConsiderations for the rational design of a Chlamydia vaccineChlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response.Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.Progesterone increases susceptibility and decreases immune responses to genital herpes infection.Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.High Physiological Concentrations of Progesterone Reverse Estradiol-Mediated Changes in Differentiation and Functions of Bone Marrow Derived Dendritic Cells.Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwayThe reproductive cycle is a pathogenic determinant during gonococcal pelvic inflammatory disease in mice.Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface.The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract.HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells.Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge.Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses.Primary human epithelial cell culture system for studying interactions between female upper genital tract and sexually transmitted viruses, HSV-2 and HIV-1.HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection.Influence of common mucosal co-factors on HIV infection in the female genital tract.A birth control vaccine is on the horizon for family planning.Latent TGF-β1 is compartmentalized between blood and seminal plasma of HIV-positive men and its activation in semen is negatively correlated with viral load and immune activation.HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium.Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.Medroxyprogesterone Acetate Regulates HIV-1 Uptake and Transcytosis but Not Replication in Primary Genital Epithelial Cells, Resulting in Enhanced T-Cell Infection.A novel role for IL-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal HSV-2 vaccination.MicroRNA-155 is required for clearance of Streptococcus pneumoniae from the nasopharynx.Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.Correction: Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway.Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection.Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women.Association of high-risk sexual behaviour with diversity of the vaginal microbiota and abundance of Lactobacillus.Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice.Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility.Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract.Polymeric immunoglobin (Ig) receptor production and IgA transcytosis in polarized primary cultures of mature rat uterine epithelial cells.Estradiol regulation of secretory component: expression by rat uterine epithelial cells.CD11b+ Dendritic Cell-Mediated Anti-Mycobacterium tuberculosis Th1 Activation Is Counterregulated by CD103+ Dendritic Cells via IL-10.
P50
Q28546013-AD230C7B-AEE6-4F4E-B70A-88E413135ED7Q33287897-54C75A41-0B3C-4783-885C-04BBF9B2111CQ33553358-E0E45906-3B94-4BC7-B884-9ECF1460CEB8Q33598330-02BB1ADA-2701-4FBB-BC4E-4ABA35046650Q33601324-D5137E08-2436-40C1-8E2C-20FB9D9357DAQ33751125-0B1519EF-500A-42A0-BAAD-E51C8B061310Q33835473-40B81E48-841B-4FF6-B459-D640923E5B35Q34186763-065FB036-D5EE-4F7F-A883-088E70EB9017Q34339797-64A0FFAE-C3EC-4BCF-A553-FBD7B13E63CBQ35985748-D144AA17-9E35-4722-B253-E4BDF83E1D18Q36009231-038BF57A-8D57-4FEF-A42C-954F30420324Q37026470-EF263854-14D9-44DD-B74A-53C541564D40Q37281753-00DD145D-2DB6-448A-BCBA-A69E9146FDA5Q37621725-3C42B064-6B00-495F-965F-6172F9FFC251Q37827574-492BD0FC-BA00-4149-8FB8-096E3515D1C3Q37836101-49285F6C-95C8-4931-93B1-1B17AABB85F9Q37836133-86967EB7-0945-48A4-90F2-E965AA72AEE0Q37945364-D8E4BBA6-ED69-461A-985F-3D556B399C6FQ38060423-C0C8D6D8-1882-4D8F-98FA-DB8EE458C6D0Q38195075-778E4377-99CD-41B0-BEBC-E87982E311E7Q38573702-F2FBFD15-1ED5-4854-884A-7D72DCF0FA99Q38972685-A5D95A04-5A15-4BED-81D9-8DAF98936B4DQ39094777-3956DA40-EC64-42B5-8523-85504E7E8FAFQ40047233-CC595515-26E2-4F30-86E3-E8A6F251BCE8Q40190981-65CCE230-ADAA-4BD1-A5F9-DCDA90C49DD3Q41583205-EB211CC9-34EB-4F2A-82ED-31A81BA37285Q41928855-F34F6FDA-BCCC-402E-A6AB-CC6ECDCBA076Q42065752-0EF88A7F-87BB-40BC-BA71-25F28C5F673CQ42267395-FDE24686-DCE7-40E2-8214-51158F604C23Q42732690-ACCC1F8A-D3F8-433E-AED0-A6D51B981E34Q43195713-BEEA7E52-BDB9-48E4-8C95-6FBA09BBCE4BQ45256808-EB2C2415-B5FD-4220-8A96-4396185D8D5FQ45388640-6C14A6A0-7BC8-465D-92B0-D6C8154A0C07Q46270150-DB7F8E22-9DD6-453D-A518-188EE3C3939AQ47582951-15ADAB98-0A1D-489F-98E8-95A2C279950FQ47589274-74F6809E-29CE-4926-90E6-5BC32751AFAFQ47626195-0F549ABA-ED10-4DB4-81D7-E5A8CD4AB34EQ47631207-767DE1AE-08D9-4947-AE88-CF4771832C02Q47634453-30BDCEBF-4672-4B55-8238-A6B6CEC888E7Q48158327-3B97759A-31CD-4B34-83A7-45EDB83094BF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Charu Kaushic
@ast
Charu Kaushic
@en
Charu Kaushic
@es
Charu Kaushic
@nl
Charu Kaushic
@sl
type
label
Charu Kaushic
@ast
Charu Kaushic
@en
Charu Kaushic
@es
Charu Kaushic
@nl
Charu Kaushic
@sl
prefLabel
Charu Kaushic
@ast
Charu Kaushic
@en
Charu Kaushic
@es
Charu Kaushic
@nl
Charu Kaushic
@sl
P106
P31
P496
0000-0002-7088-2569